Bicycle Therapeutics plc (BCYC) NASDAQ

4.74

+0.02(+0.42%)

Updated at May 13 04:00PM

Currency In USD

Valuation

Market Cap490.5M
Enterprise Value-120.09M
P/E Ratio-1.51
PEG Ratio0.41
Price/Sales Ratio5.17
Price/Book Ratio0.6
Enterprise/Revenue-3.42
Enterprise/EBITDA1.03

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-3.45
Operating Margin-3.82

Management Effectiveness

Return On Assets-0.34
Return On Equity-0.36

Income Statement

Revenue72.59M
Revenue/Share0.91
Gross Profit72.59M
EBITDA-212.18M
Net Income-218.96M
Diluted EPS-3.16

Balance Sheet

Total Cash559.47M
Total Cash/Share8.03
Total Debt13.87M
Total Debt/Equity0.03
Current Ratio12.66
Book Value Per Share7.95

Price History

52-Week Change-41.55
52-Week High9.36
52-Week Low4.24
Moving Average 50 Days4.9
Moving Average 200 Days6.5

Statistics

Average Volume449,637
Shares Outstanding69.26M
% Held by Institutions56.52

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A